CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 51 filers reported holding CATALYST BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,297,000 | -10.9% | 301,678 | +21.6% | 0.62% | -1.3% |
| Q2 2020 | $1,456,000 | -13.0% | 248,050 | -35.2% | 0.62% | -20.1% |
| Q1 2020 | $1,673,000 | -37.3% | 382,900 | -2.3% | 0.78% | -33.3% |
| Q4 2019 | $2,669,000 | -2.6% | 391,894 | -29.8% | 1.17% | -22.9% |
| Q3 2019 | $2,741,000 | -32.0% | 558,159 | +2.0% | 1.52% | -25.2% |
| Q2 2019 | $4,032,000 | +2.7% | 547,092 | +13.0% | 2.03% | +18.3% |
| Q1 2019 | $3,927,000 | +6.6% | 484,200 | +3.7% | 1.72% | -9.7% |
| Q4 2018 | $3,684,000 | +44.5% | 466,900 | +97.4% | 1.90% | +33.8% |
| Q3 2018 | $2,550,000 | – | 236,558 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Colorado Capital Management, Inc. | 34,165 | $12 | 0.01% |
| JOHNSON & JOHNSON | 66,951 | $23,540 | 0.01% |
| Kynam Capital Management, LP | 89,886 | $31,604 | 0.00% |
| Nantahala Capital Management | 67,800 | $23,838 | 0.00% |
| Virtu Financial LLC | 48,633 | $17 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $7,032 | 0.00% |
| MORGAN STANLEY | 76,098 | $26,756 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 144,028 | $50 | 0.00% |
| BlackRock Inc. | 153,657 | $54,026 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 55,043 | $19,353 | 0.00% |